Technical Analysis for GKOS - Glaukos Corporation

Grade Last Price % Change Price Change
grade F 62.81 0.96% 0.60
GKOS closed up 0.96 percent on Monday, November 11, 2019, on 1.39 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical GKOS trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Calm After Storm Range Contraction 0.00%
Earnings Movers Other 0.96%
Multiple of Ten Bullish Other 0.96%
Inside Day Range Contraction 0.96%
Lower Bollinger Band Touch Weakness 0.96%
MACD Bearish Centerline Cross Bearish 6.53%
MACD Bearish Signal Line Cross Bearish 6.53%
Expansion Pivot Sell Setup Bearish Swing Setup 6.53%
Volume Surge Other 6.53%

Older signals for GKOS ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Glaukos Corporation (Glaukos) is an ophthalmic medical technology company. The Company is engaged in the development and commercialization of products and procedures for the treatment of glaucoma. Glaukos has developed the micro-invasive glaucoma surgery (MIGS) for glaucoma treatment. It offers iStent, an MIGS device measuring one millimeter long and 0.33 millimeter wide. MIGS procedures involve the insertion of a micro-scale device from within the eye's anterior chamber through a small corneal incision. Glaukos is also engaged in developing a portfolio of micro-scale injectable therapies, including three pipeline products, namely, the iStent Inject, the iStent Supra and iDose. The iStent Inject includes two stents pre-loaded in an auto-injection inserter. The iStent Supra is designed to access an alternative drainage space within the eye. iDose is an implant that is designed to provide a sustained release of a prostaglandin drug to lower intraocular pressure in glaucoma patients.
Medicine Surgery Glaucoma Ophthalmology Implant Vision Blindness Drainage Incision Treatment Of Glaucoma Eye Surgery Pipeline Products Intraocular Pressure
Is GKOS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 84.65
52 Week Low 50.6
Average Volume 460,579
200-Day Moving Average 69.5858
50-Day Moving Average 64.8566
20-Day Moving Average 63.663
10-Day Moving Average 63.65
Average True Range 2.713
ADX 16.87
+DI 17.3085
-DI 29.7296
Chandelier Exit (Long, 3 ATRs ) 58.561
Chandelier Exit (Short, 3 ATRs ) 64.309
Upper Bollinger Band 66.8872
Lower Bollinger Band 60.4388
Percent B (%b) 0.37
BandWidth 10.12896
MACD Line -0.3891
MACD Signal Line -0.2306
MACD Histogram -0.1585
Fundamentals Value
Market Cap 2.16 Billion
Num Shares 34.4 Million
EPS -0.04
Price-to-Earnings (P/E) Ratio -1570.25
Price-to-Sales 8.40
Price-to-Book 9.34
PEG Ratio -14.23
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 66.73
Resistance 3 (R3) 66.73 65.43 66.07
Resistance 2 (R2) 65.43 64.43 65.43 65.85
Resistance 1 (R1) 64.12 63.82 64.78 64.12 65.64
Pivot Point 62.82 62.82 63.15 62.82 62.82
Support 1 (S1) 61.51 61.82 62.17 61.51 59.98
Support 2 (S2) 60.21 61.21 60.21 59.77
Support 3 (S3) 58.90 60.21 59.55
Support 4 (S4) 58.90